MYOCARDIAL VIABILITY ASSESSMENT IN ISCHEMIC CARDIOMYOPATHY - BENEFITS OF CORONARY REVASCULARIZATION

被引:149
|
作者
DREYFUS, GD
DUBOC, D
BLASCO, A
VIGONI, F
DUBOIS, C
BRODATY, D
DELENTDECKER, P
BACHET, J
GOUDOT, B
GUILMET, D
机构
[1] Department of Cardio-Vascular Surgery and Transplantation, Hôpital Foch, Paris V University, Suresnes
来源
ANNALS OF THORACIC SURGERY | 1994年 / 57卷 / 06期
关键词
D O I
10.1016/0003-4975(94)90091-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with ischemic heart disease, congestive heart failure, and low ejection fraction are usually referred for orthotopic heart transplantation. Based on results of myocardial viability assessment, we have prospectively used either coronary artery bypass grafting or orthotopic heart transplantation. From January 1990 to June 1992, among 50 patients initially referred for heart transplantation, 46 showing myocardial viability underwent bypass grafting. Forty-five of these 46 patients were men, and the mean age was 58 +/- 12 years (range, 40 to 70 years). Congestive heart failure was present in all patients, and dyspnea was the main symptom in 80% (37/46). Patients were selected according to three criteria. (1) Myocardial viability was primarily assessed by thallium scintigraphy for up to 24 hours (28/46 patients). When results were negative, patients underwent positron emission tomography (20/46 patients). (2) Regional left ventricular function was assessed using gated blood pool single-photon emission computed tomography combined with (3) full hemodynamic evaluation. Results were as follows: end-diastolic volume, 129 +/- 35 mL/m(2); ejection fraction, 0.23 +/- 0.06; cardiac index, 2.4 +/- 0.62 L . min(-1) . m(-2); mean pulmonary artery pressure, 26 +/- 0.90 mm Hg; and mean pulmonary capillary wedge pressure, 16 +/- 1.10 mm Hg. Operative mortality was 2.17% (1/46). During follow-up (mean duration, 18 months), there were three late cardiac-related deaths (arrhythmias) and two noncardiac-related deaths. The 40 long-term survivors are in New York Heart Association class II. Angiography (15 patients) or gated blood pool single photon emission tomography (32) showed improvement in mean ejection fraction to 0.39 +/- 0.13 (range, 0.22 to 0.46). We therefore recommend coronary artery bypass grafting as an alternative to orthotopic heart transplantation whenever myocardial viability is detected by thallium scintigraphy or positron emission tomography, cardiac index is 1.5 L . min(-1) . m(-2) or higher, and mean pulmonary pressure is 40 mm Hg or lower.
引用
收藏
页码:1402 / 1408
页数:7
相关论文
共 50 条
  • [21] Revascularization in ischemic cardiomyopathy. Is viability testing still viable?
    Howick, James F.
    Gersh, Bernard J.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2025, 78 (02): : 78 - 81
  • [22] Myocardial revascularization in patients with ischemic cardiomyopathy: Functional observations
    Salati, M
    Lemma, M
    Di Mattia, DG
    Danna, P
    Cialfi, A
    Salvaggio, A
    Santoli, C
    ANNALS OF THORACIC SURGERY, 1997, 64 (06): : 1728 - 1734
  • [23] Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
    Liga, Riccardo
    Colli, Andrea
    Taggart, David P. P.
    Boden, William E. E.
    De Caterina, Raffaele
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (06):
  • [24] Assessment of myocardial viability in patients before revascularization
    Borreguero, LJJ
    Ruiz-Salmerón, R
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (07): : 721 - 733
  • [25] Assessment of myocardial viability in postinfarction and indications of revascularization
    Zouaoui, W.
    Ouldzein, H.
    Carrie, D.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2010, 59 (02): : 79 - 85
  • [26] ISCHEMIC CARDIOMYOPATHY - CRITERIA FOR CORONARY REVASCULARIZATION AND CARDIAC TRANSPLANTATION
    LOUIE, HW
    LAKS, H
    MILGALTER, E
    DRINKWATER, DC
    HAMILTON, MA
    BRUNKEN, RC
    STEVENSON, LW
    CIRCULATION, 1991, 84 (05) : 290 - 295
  • [27] ISCHEMIC CARDIOMYOPATHY - CRITERIA FOR CORONARY REVASCULARIZATION AND CARDIAC TRANSPLANTATION
    LOUIE, HW
    LAKS, H
    MILGALTER, E
    DRINKWATER, DC
    HAMILTON, MA
    STEVENSON, LW
    CIRCULATION, 1990, 82 (04) : 362 - 362
  • [28] PREDICTING SURVIVAL AFTER CORONARY REVASCULARIZATION FOR ISCHEMIC CARDIOMYOPATHY
    LANGENBURG, SE
    BUCHANAN, SA
    BLACKBOURNE, LH
    SCHERI, RP
    SINCLAIR, KN
    MARTINEZ, J
    SPOTNITZ, WD
    TRIBBLE, CG
    KRON, IL
    ANNALS OF THORACIC SURGERY, 1995, 60 (05): : 1193 - 1197
  • [29] Evaluation of myocardial viability in chronic ischemic cardiomyopathy - Response
    Bax, JJ
    van der Wall, EE
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2003, 19 (02): : 137 - 140
  • [30] Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy
    Schuster, Andreas
    Paul, Matthias
    Bettencourt, Nuno
    Morton, Geraint
    Chiribiri, Amedeo
    Ishida, Masaki
    Hussain, Shazia
    Jogiya, Roy
    Kutty, Shelby
    Bigalke, Boris
    Perera, Divaka
    Nagel, Eike
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (02) : 413 - 420